β-Amyloid (25-35), HFIP-treated
β-Amyloid (25-35) (Amyloid beta-peptide (25-35) ), HFIP-treated is a β-Amyloid (25-35) (HY-P0128) treated with HFIP. β-Amyloid (25-35) (Amyloid beta-peptide (25-35) ) is the fragment Aβ (25-35) of the Alzheimer's amyloid β-peptide, has shown neurotoxic activities in cultured cells[1].
Product Specifications
CAS Number
[131602-53-4]
Product Name Alternative
Amyloid beta-peptide (25-35), HFIP-treated; Aβ25-35, HFIP-treated; β-Amyloid peptide (25-35), HFIP-treated
UNSPSC
12352209
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Purity
99.71
Smiles
Molecular Formula
C45H81N13O14S
Molecular Weight
1060.27
References & Citations
[1]D'Ursi AM, et al. Solution structure of amyloid beta-peptide (25-35) in different media. J Med Chem. 2004 Aug 12;47 (17) :4231-8.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
